Alpine Immune Sciences Financials

Alpine Immune Stock Summary

Alpine Immune competes with Terns Pharmaceuticals, Day One, Acumen Pharmaceuticals, Amylyx Pharmaceuticals, and MoonLake Immunotherapeuti. Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmuneinflammatory disorders, and other diseases. Alpine Immune Sciences, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington. Alpine Immune operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 85 people.

Alpine Immune Key Financial Ratios

Alpine Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Alpine Immune's current stock value. Our valuation model uses many indicators to compare Alpine Immune value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Alpine Immune competition to find correlations between indicators driving Alpine Immune's intrinsic value. More Info.Alpine Immune Sciences is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Alpine Immune's earnings, one of the primary drivers of an investment's value.

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

If you are still planning to invest in Alpine Immune Sciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Alpine Immune's history and understand the potential risks before investing.